Brief: TCBP Announces MHRA Acceptance Of Amendment For ACHIEVE UK Trial
22/02/2024 14:46
Feb 22 (Reuters) - TC BioPharm Ltd T0Uy.F :
* TCBP ANNOUNCES MHRA ACCEPTANCE OF AMENDMENT FOR ACHIEVE UK
TRIAL
* TC BIOPHARM LTD: INCREASES DOSE LEVEL IN LINE WITH COHORT
2 IN
IND
* TC BIOPHARM LTD: CHANGES FROM "IN PATIENT" TO "OUT
PATIENT"
PROCEDURE
Source text for Eikon: ID:nPn3PRCsxa
Further company coverage: T0Uy.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange